PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-3460

  1. bar
    681 Posts.
    lightbulb Created with Sketch. 107
    Did PPS recently get DMOAD status for vetinary application from the venerable FDA? If so it stands to reason that our exalted IPPS will succeed with our future application for similar recognition. The animal lobby is as strict as the human one. OMHO.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
24.0¢ 25.0¢ 23.0¢ $101.6K 424.7K

Buyers (Bids)

No. Vol. Price($)
12 144266 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 18540 1
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.